Concepedia

David B. Zhen

DB

14

Publications

966

Citations

14

H-Index

2014

Active since

Affiliations

Fred Hutch Cancer Center(Current)

University of Michigan

University of Washington

University of Washington Medical Center

The University of Texas MD Anderson Cancer Center

David B. Zhen is an author at Fred Hutch Cancer Center specializing in medicine, cancer research, and oncology.

Top concepts

MedicineOncologyCancer ResearchPathologyRadiation OncologyCancer TherapyTumor BiologyMolecular OncologyImmunologyPharmacology

Publications per year

2014–2024

14

Publications

14

BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study

David B. Zhen, Kari G. Rabe, Steven Gallinger et al. · Genetics in Medicine · 2014 · 288 citations · Full text

Tumor Biology, Pancreatic Cancer, Somatic Variant +11

Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study

Do‐Youn Oh, Aiwu Ruth He, Mohamed Bouattour et al. · The Lancet. Gastroenterology & hepatology · 2024 · 196 citations · Full text

Overall Survival, Gastrointestinal Oncology, Medicine +7

Hereditary ATTR amyloidosis: a single-institution experience with 266 patients

Paul Swiecicki, David B. Zhen, Michelle L. Mauermann et al. · Amyloid · 2015 · 98 citations

Metformin Use and Survival of Patients With Pancreatic Cancer: A Cautionary Lesson

Roongruedee Chaiteerakij, Gloria M. Petersen, William R. Bamlet et al. · Journal of Clinical Oncology · 2016 · 79 citations · Full text

A randomized phase 2 trial of nivolumab, gemcitabine, and cisplatin or nivolumab and ipilimumab in previously untreated advanced biliary cancer: <scp>BilT</scp>‐01

Vaibhav Sahai, Kent A. Griffith, Muhammad S. Beg et al. · Cancer · 2022 · 54 citations · Full text

Rows per page

1–5 of 14